Fig. 4From: Liquid biopsy using ascitic fluid and pleural effusion supernatants for genomic profiling in gastrointestinal and lung cancersThe mutation detection ability of PE supernatant and plasma in 139 lung cancer patients with paired samples. PE supernatant had higher MSAF A and more mutations B than plasma. PE supernatant had higher driver mutation detected rate than plasma CBack to article page